Literature DB >> 31934133

Proinflammatory-factors-carrying-microvesicles from monocytes induced by high glucose enhance the activation of HIF/VEGF pathway in human renal mesangial cells.

Mingzhen Li1, Jing Yu1, Lirong Sun1.   

Abstract

OBJECTIVES: Renal mesangial expansion has been identified as a major factor contributing to glomerulosclerosis, a typical symptom of diabetic nephropathy. It is unclear whether microvesicles, known as a mediator for cross-talk between cells and organs, are involved in a profibrotic process. In this study, we are the first to investigate the effect of monocyte-derived microvesicles induced by high glucose on renal mesangial cells.
METHODS: THP1 cells were evoked by high glucose to generate microvesicles, quantified by ELISA. Glucose uptake by THP1 cells was measured using fluorescently-labeled deoxyglucose analog 2-NBDG as a probe. The contents of inflammatory cytokines in microvesicles were detected by western blot. The expressions of HIF-1α and VEGF in human renal mesangial cells after treatment with THP1-derived microvesicles were examined by western blot.
RESULTS: The glucose uptake by THP1 cells was significantly increased after high glucose treatment. High glucose significantly evoked MV generation, which contained increased protein level of IL-6, 8 and MCP-1. The expressions of HIF-1α and VEGF in HRMC were augmented by microvesicles.
CONCLUSIONS: Our study indicates that monocyte-derived MVs induced by high glucose can carry proinflammatory factors, and enhance the expression of the HIF/VEGF pathway in human renal mesangial cells. Our findings may provide a novel potential mechanism in the progression of diabetic nephropathy. IJCEP
Copyright © 2019.

Entities:  

Keywords:  Microvesicles; high glucose; proinflammatory factors; renal mesangial cells

Year:  2019        PMID: 31934133      PMCID: PMC6949718     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  9 in total

1.  Circulating microparticles levels are increased in patients with diabetic kidney disease: A case-control research.

Authors:  Kathryna Fontana Rodrigues; Nathalia Teixeira Pietrani; Ana Paula Fernandes; Adriana Aparecida Bosco; Maira Cândida Rodrigues de Sousa; Ieda de Fátima Oliveira Silva; Josianne Nicácio Silveira; Fernanda Magalhães Freire Campos; Karina Braga Gomes
Journal:  Clin Chim Acta       Date:  2018-01-03       Impact factor: 3.786

Review 2.  Hypoxia-inducible factor activation in diabetic kidney disease.

Authors:  Patrik Persson; Fredrik Palm
Journal:  Curr Opin Nephrol Hypertens       Date:  2017-09       Impact factor: 2.894

3.  High glucose activates HIF-1-mediated signal transduction in glomerular mesangial cells through a carbohydrate response element binding protein.

Authors:  Tsubasa Isoe; Yuichi Makino; Katsutoshi Mizumoto; Hidemitsu Sakagami; Yukihiro Fujita; Jun Honjo; Yumi Takiyama; Hiroshi Itoh; Masakazu Haneda
Journal:  Kidney Int       Date:  2010-04-07       Impact factor: 10.612

4.  Mir-217 promotes inflammation and fibrosis in high glucose cultured rat glomerular mesangial cells via Sirt1/HIF-1α signaling pathway.

Authors:  Ying Shao; Chuan Lv; Can Wu; Yuehong Zhou; Qiuyue Wang
Journal:  Diabetes Metab Res Rev       Date:  2016-04-21       Impact factor: 4.876

5.  Cholesterol enrichment of human monocyte/macrophages induces surface exposure of phosphatidylserine and the release of biologically-active tissue factor-positive microvesicles.

Authors:  Ming-Lin Liu; Michael P Reilly; Peter Casasanto; Steven E McKenzie; Kevin Jon Williams
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-12-07       Impact factor: 8.311

6.  Changes of serum Mir-217 and the correlation with the severity in type 2 diabetes patients with different stages of diabetic kidney disease.

Authors:  Ying Shao; Huiwen Ren; Chuan Lv; Xiaoyu Ma; Can Wu; Qiuyue Wang
Journal:  Endocrine       Date:  2016-08-13       Impact factor: 3.633

Review 7.  Function and role of microparticles in various clinical settings.

Authors:  Shosaku Nomura; Yukio Ozaki; Yasuo Ikeda
Journal:  Thromb Res       Date:  2008-07-29       Impact factor: 3.944

8.  Urinary Exosomal mRNA of WT1 as Diagnostic and Prognostic Biomarker for Diabetic Nephropathy.

Authors:  Hideharu Abe; Akiko Sakurai; Hiroyuki Ono; Sanae Hayashi; Sakiya Yoshimoto; Arisa Ochi; Sayo Ueda; Kenji Nishimura; Eriko Shibata; Masanori Tamaki; Fumi Kishi; Seiji Kishi; Taichi Murakami; Kojiro Nagai; Toshio Doi
Journal:  J Med Invest       Date:  2018

Review 9.  Therapeutic angiogenesis by vascular endothelial growth factor supplementation for treatment of renal disease.

Authors:  Omar C Logue; Jeremy W D McGowan; Eric M George; Gene L Bidwell
Journal:  Curr Opin Nephrol Hypertens       Date:  2016-09       Impact factor: 2.894

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.